This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Friday's Small-Cap Winners & Losers

Inspire Pharma (ISPH) gained on word it will take over commercializing InSite Vision's (ISV) eye-infection drug, AzaSite, in the U.S. and Canada. Inspire shares were rising 38 cents, or 5.2%, to $7.75.

LookSmart (LOOK) shares were sliding on soft guidance. The Internet search-engine operator said 2007 revenue will grow by 20% to 25% from 2006's top line of $48.8 million, meaning a range between $58.6 million and $61 million. Two analysts are seeking sales of $70.2 million. Fourth-quarter revenue, at $15 million, was slightly under the $15.5 million target. Shares were down 90 cents, or 16.7%, to $4.48.

Canada's Westaim (WEDX) was plunging after the firm -- which owns companies dealing in flat-panel display products, wound-care products and pharmaceuticals -- widened its losses from continuing operations and saw slightly lower revenue than it did last year. Shares were sinking 20 cents, or 15.9%, to $1.06.

Sonic Solutions (SNIC) was lower after the business-software company said it will need to restate downward its prior financials for "material" noncash stock-option charges. It can't yet provide any monetary specifics. The Novato, Calif., company also said revenue for the quarter ended Dec. 31 totaled $39.1 million, which barely misses the $40.9 million mean projection. Shares were down $1.96, or 12.2%, to $14.07.

Pacificnet (PACT) sank on word of management changes. Joseph Levinson, who was appointed chief financial officer less than six months ago, is being replaced by Daniel Lui, formerly of KPMG and PricewaterhouseCoopers. The China-based communications-technology company was slumping by 43 cents, or 6.6%, to $6.12.
2 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
LOOK $0.65 -8.45%
CAPA $0.45 0.00%
HURC $24.63 0.00%
AAPL $94.02 0.00%
FB $104.07 0.00%


Chart of I:DJI
DOW 16,204.97 -211.61 -1.29%
S&P 500 1,880.05 -35.40 -1.85%
NASDAQ 4,363.1440 -146.4150 -3.25%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs